WUTIF Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Naegis Pharmaceuticals Inc.naegispharma.comApr 2024
Naegis Pharmaceuticals is a retina-focused ophthalmology company developing oral and topical small-molecule therapies that inhibit both LTB4 and cysteinyl leukotrienes as non-injection treatments for inflammatory eye diseases such as AMD, diabetic retinopathy, and uveitis.
BiotechHealthtechVancouver
Philip Davies(Director)Michael Liggett(Director)Julian Gangolli(Director)Cameron Groome(Director)David Burgoyne(Executive Officer, Director)Ian McBeath(Executive Officer, Director)
PartnerMike Volker· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.